REPORT ID 2314

United States Oral Solid Dosage Pharmaceutical Formulation Market Report 2017

Publish Date
8-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the United States Oral Solid Dosage Pharmaceutical Formulation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation in these regions, from 2012 to 2022 (forecast).

United States Oral Solid Dosage Pharmaceutical Formulation market competition by top manufacturers/players, with Oral Solid Dosage Pharmaceutical Formulation sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca Plc.
    Bristol-Myers Squibb Company
    Eli Lilly and Company
    Gilead Sciences
    Merck & Co. Inc.
    Novartis AG
    Pfizer Inc.
    AbbVie Inc.
    Boehringer Ingelheim GmbH
    Hoffman-La-Roche Ltd.
    Johnson & Johnson
    Biogen Inc.
    Bayer AG
    Teva Pharmaceticals
    Amgen Inc.
    Takeda Pharmaceutical Company Ltd.
    Otsuka Pharmaceutical Co., Ltd.
    Shire Plc.
    Celgene Corporation
    Astellas Pharma Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    By Form
        Capsules
        Powders
        Tablets
    By Drug Release Mechanism
        Immediate Release
        Extended Release
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Oral Solid Dosage Pharmaceutical Formulation Market Report 2017
1 Oral Solid Dosage Pharmaceutical Formulation Overview
    1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation
    1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation by Product Category
        1.2.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Capsules
        1.2.4 Powders
        1.2.5 Tablets
    1.3 United States Oral Solid Dosage Pharmaceutical Formulation Market by Application/End Users
        1.3.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 United States Oral Solid Dosage Pharmaceutical Formulation Market by Region
        1.4.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
        1.4.3 Southwest Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
        1.4.5 New England Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
        1.4.6 The South Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
        1.4.7 The Midwest Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Oral Solid Dosage Pharmaceutical Formulation (2012-2022)
        1.5.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2022)
        1.5.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2022)

2 United States Oral Solid Dosage Pharmaceutical Formulation Market Competition by Players/Suppliers
    2.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Oral Solid Dosage Pharmaceutical Formulation Average Price by Players/Suppliers (2012-2017)
    2.4 United States Oral Solid Dosage Pharmaceutical Formulation Market Competitive Situation and Trends
        2.4.1 United States Oral Solid Dosage Pharmaceutical Formulation Market Concentration Rate
        2.4.2 United States Oral Solid Dosage Pharmaceutical Formulation Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Oral Solid Dosage Pharmaceutical Formulation Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oral Solid Dosage Pharmaceutical Formulation Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Region (2012-2017)
    3.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Region (2012-2017)
    3.3 United States Oral Solid Dosage Pharmaceutical Formulation Price by Region (2012-2017)

4 United States Oral Solid Dosage Pharmaceutical Formulation Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2012-2017)
    4.3 United States Oral Solid Dosage Pharmaceutical Formulation Price by Type (2012-2017)
    4.4 United States Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Type (2012-2017)

5 United States Oral Solid Dosage Pharmaceutical Formulation Sales (Volume) by Application (2012-2017)
    5.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application (2012-2017)
    5.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Oral Solid Dosage Pharmaceutical Formulation Players/Suppliers Profiles and Sales Data
    6.1 AstraZeneca Plc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb Company
        6.2.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eli Lilly and Company
        6.3.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Gilead Sciences
        6.4.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Merck & Co. Inc.
        6.5.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Novartis AG
        6.6.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Pfizer Inc.
        6.7.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 AbbVie Inc.
        6.8.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Boehringer Ingelheim GmbH
        6.9.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Hoffman-La-Roche Ltd.
        6.10.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Johnson & Johnson
    6.12 Biogen Inc.
    6.13 Bayer AG
    6.14 Teva Pharmaceticals
    6.15 Amgen Inc.
    6.16 Takeda Pharmaceutical Company Ltd.
    6.17 Otsuka Pharmaceutical Co., Ltd.
    6.18 Shire Plc.
    6.19 Celgene Corporation
    6.20 Astellas Pharma Inc.

7 Oral Solid Dosage Pharmaceutical Formulation Manufacturing Cost Analysis
    7.1 Oral Solid Dosage Pharmaceutical Formulation Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Oral Solid Dosage Pharmaceutical Formulation Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Forecast by Type (2017-2022)
    11.3 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Forecast by Application (2017-2022)
    11.4 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer